Peer Review History
| Original SubmissionDecember 16, 2024 |
|---|
|
Dear Dr. Liu, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. ============================== ACADEMIC EDITOR: ============================== Please submit your revised manuscript by Jun 05 2025 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org . When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.
If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols . Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols . We look forward to receiving your revised manuscript. Kind regards, Hoh Boon-Peng, PhD Academic Editor PLOS ONE Journal Requirements: When submitting your revision, we need you to address these additional requirements. 1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and 2. Thank you for stating in your Funding Statement: “The TwinLife study was funded by the German Research Foundation (Grant No. 220286500), with funding awarded to Martin Diewald, Christian Kandler, Frank M. Spinath, Bastian Mönkediek, and Rainer Riemann. The molecular genetic extension of TwinLife was also funded by the German Research Foundation (Grant No. 428902522), with funding awarded to Martin Diewald, Peter Krawitz, Markus M. Nöthen, Rainer Riemann, and Frank M. Spinath. The funders had no role in the study design, data collection and analysis, decision to publish, or manuscript preparation. YL and MR are supported by the TwinLife project, while NVH is funded by the European Union’s HORIZON-MSCA-2021-DN-01 programme (Grant No. 101073237). “Please provide an amended statement that declares *all* the funding or sources of support (whether external or internal to your organization) received during this study, as detailed online in our guide for authors at http://journals.plos.org/plosone/s/submit-now. Please also include the statement “There was no additional external funding received for this study.” in your updated Funding Statement. Please include your amended Funding Statement within your cover letter. We will change the online submission form on your behalf. 3. We note that you have indicated that there are restrictions to data sharing for this study. For studies involving human research participant data or other sensitive data, we encourage authors to share de-identified or anonymized data. However, when data cannot be publicly shared for ethical reasons, we allow authors to make their data sets available upon request. For information on unacceptable data access restrictions, please see http://journals.plos.org/plosone/s/data-availability#loc-unacceptable-data-access-restrictions. Before we proceed with your manuscript, please address the following prompts: a) If there are ethical or legal restrictions on sharing a de-identified data set, please explain them in detail (e.g., data contain potentially identifying or sensitive patient information, data are owned by a third-party organization, etc.) and who has imposed them (e.g., a Research Ethics Committee or Institutional Review Board, etc.). Please also provide contact information for a data access committee, ethics committee, or other institutional body to which data requests may be sent. b) If there are no restrictions, please upload the minimal anonymized data set necessary to replicate your study findings to a stable, public repository and provide us with the relevant URLs, DOIs, or accession numbers. Please see http://www.bmj.com/content/340/bmj.c181.long for guidelines on how to de-identify and prepare clinical data for publication. For a list of recommended repositories, please see https://journals.plos.org/plosone/s/recommended-repositories. You also have the option of uploading the data as Supporting Information files, but we would recommend depositing data directly to a data repository if possible. Please update your Data Availability statement in the submission form accordingly. 4. Thank you for stating the following in the Acknowledgments Section of your manuscript: “, Rainer Riemann, and Frank M. Spinath. The funders had no role in the study design, data collection and analysis, decision to publish, or manuscript preparation. YL and MR are supported by the TwinLife project, while NVH was funded by the European Union, under project #101073237 – European Society of Social Genetics Network. We would like to thank Charlotte Pahnke, Andreas Forstner, Markus Nöthen, Carlo Maj, and Shirin Zare for their contributions to DNA extraction and polygenic score calculations” We note that you have provided additional information within the Acknowledgements Section that is not currently declared in your Funding Statement. Please note that funding information should not appear in the Acknowledgments section or other areas of your manuscript. We will only publish funding information present in the Funding Statement section of the online submission form. Please remove any funding-related text from the manuscript and let us know how you would like to update your Funding Statement. Currently, your Funding Statement reads as follows: “The TwinLife study was funded by the German Research Foundation (Grant No. 220286500), with funding awarded to Martin Diewald, Christian Kandler, Frank M. Spinath, Bastian Mönkediek, and Rainer Riemann. The molecular genetic extension of TwinLife was also funded by the German Research Foundation (Grant No. 428902522), with funding awarded to Martin Diewald, Peter Krawitz, Markus M. Nöthen, Rainer Riemann, and Frank M. Spinath. The funders had no role in the study design, data collection and analysis, decision to publish, or manuscript preparation. YL and MR are supported by the TwinLife project, while NVH is funded by the European Union’s HORIZON-MSCA-2021-DN-01 programme (Grant No. 101073237).” Please include your amended statements within your cover letter; we will change the online submission form on your behalf. 5. Please review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text, or remove these references and replace them with relevant current references. Any changes to the reference list should be mentioned in the rebuttal letter that accompanies your revised manuscript. If you need to cite a retracted article, indicate the article’s retracted status in the References list and also include a citation and full reference for the retraction notice. [Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. Is the manuscript technically sound, and do the data support the conclusions? Reviewer #1: Yes ********** 2. Has the statistical analysis been performed appropriately and rigorously? -->?> Reviewer #1: Yes ********** 3. Have the authors made all data underlying the findings in their manuscript fully available??> The PLOS Data policy Reviewer #1: Yes ********** 4. Is the manuscript presented in an intelligible fashion and written in standard English??> Reviewer #1: Yes ********** Reviewer #1: PONE-D-24-57036 Neighbourhood Deprivation, Genetic Predisposition, and Life Satisfaction: Evidence from the German Twin Family Panel Interesting and excellent study. Overall, the study is important and contributes to the genetic and psychology research area. There are some suggestions and comments as below: (1) The study is focusing on gene-environment interactions (GxE) on individual life satisfaction. Participants between 10 and 24 years old. There is a big gap in individual developmental stages. From a psychological view, it involved the development from early adolescence to young adults. Many other factors (including developmental tasks) will influence individual life satisfaction. Kindly justify. (2) Life Satisfaction—Instrument a) How many total items were used for data collection? b) What do you mean by “comprising five items each”? c) How does CFA use to measure satisfaction level? Any data for CFA? The below statement is a bit confusing. Kindly revise and justify. “The final life satisfaction score was created using confirmatory factor analysis of the raw indicators” . (3) Methodology – Data Collection. a) Kindly justify when the data collection is done. The below statements are not reported deeply. “The data were accessed for research purposes on May 2024.” “Data collection for the Face-to-Face (F2F 1) survey occurred in two phases: Subsample A was collected between September 28, 2014, and May 28, 2015, while Subsample B was collected between September 16, 2015, and April 18, 2016” (4) Family SES is measured as a factor based on parental years of education, occupational status (ISEI), and OECD household net income. However, it is not reported clearly in the main document. Kindly justify and report the data for the below statements: “ .. in the statistical analysis we additionally control for family SES, measured as a factor based on parental years of education, occupational status (ISEI) and OECD household net income. Additionally, we control for birth cohort status, using a categorical variable indicating whether a twin belongs to cohort 2, 3, or 4.” (5) Discussion lacks citation or previous study to support. Suggest discussing the findings through theories as mentioned in the subheading “Theoretical Framework.”. Also, discuss the main finding and overall contribution. (6) Suggest to add the subheading “Implication and Recommendation” – Explain the implication from a theoretical and practical view. How does this study contribute to both the genetic and psychology areas? ********** what does this mean? ). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy Reviewer #1: No ********** [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/ . PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org
|
| Revision 1 |
|
<p>Neighborhood Context, Genetic influences, and Life Satisfaction: Evidence from the German Twin Family Panel PONE-D-24-57036R1 Dear Dr. Harerimana, We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements. Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication. An invoice will be generated when your article is formally accepted. Please note, if your institution has a publishing partnership with PLOS and your article meets the relevant criteria, all or part of your publication costs will be covered. Please make sure your user information is up-to-date by logging into Editorial Manager at Editorial Manager® and clicking the ‘Update My Information' link at the top of the page. For questions related to billing, please contact billing support . If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. Kind regards, Hoh Boon-Peng, PhD Academic Editor PLOS ONE Additional Editor Comments (optional): The comments have been addressed accordingly, hence recommend accept for publication Reviewers' comments: Reviewer's Responses to Questions Comments to the Author Reviewer #1: All comments have been addressed ********** 2. Is the manuscript technically sound, and do the data support the conclusions??> Reviewer #1: Yes ********** 3. Has the statistical analysis been performed appropriately and rigorously? -->?> Reviewer #1: Yes ********** 4. Have the authors made all data underlying the findings in their manuscript fully available??> The PLOS Data policy Reviewer #1: Yes ********** 5. Is the manuscript presented in an intelligible fashion and written in standard English??> Reviewer #1: Yes ********** Reviewer #1: Accept with no further comments. Thank you. ********** what does this mean? ). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy Reviewer #1: No ********** |
| Formally Accepted |
|
PONE-D-24-57036R1 PLOS ONE Dear Dr. Harerimana, I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now being handed over to our production team. At this stage, our production department will prepare your paper for publication. This includes ensuring the following: * All references, tables, and figures are properly cited * All relevant supporting information is included in the manuscript submission, * There are no issues that prevent the paper from being properly typeset You will receive further instructions from the production team, including instructions on how to review your proof when it is ready. Please keep in mind that we are working through a large volume of accepted articles, so please give us a few days to review your paper and let you know the next and final steps. Lastly, if your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. You will receive an invoice from PLOS for your publication fee after your manuscript has reached the completed accept phase. If you receive an email requesting payment before acceptance or for any other service, this may be a phishing scheme. Learn how to identify phishing emails and protect your accounts at https://explore.plos.org/phishing. If we can help with anything else, please email us at customercare@plos.org. Thank you for submitting your work to PLOS ONE and supporting open access. Kind regards, PLOS ONE Editorial Office Staff on behalf of Professor Dr Hoh Boon-Peng Academic Editor PLOS ONE |
Open letter on the publication of peer review reports
PLOS recognizes the benefits of transparency in the peer review process. Therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. Reviewers remain anonymous, unless they choose to reveal their names.
We encourage other journals to join us in this initiative. We hope that our action inspires the community, including researchers, research funders, and research institutions, to recognize the benefits of published peer review reports for all parts of the research system.
Learn more at ASAPbio .